These findings are supported by other studies that reported suppression of LH and FSH levels with GnRH antagonists in healthy women (21, 22) and demonstrated reductions in circulating LH, FSH, and estradiol levels after GnRH antagonist treatment in patients with PCOS (23). Here, PLOD1 is linked to polycystic ovary syndrome.